717 research outputs found

    Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives

    Get PDF
    While modern treatments have led to a dramatic improvement in survival for pediatric malignancy, toxicities are high and a significant proportion of patients remain resistant. Gene transfer offers the prospect of highly specific therapies for childhood cancer. “Corrective” genes may be transferred to overcome the genetic abnormalities present in the precancerous cell. Alternatively, genes can be introduced to render the malignant cell sensitive to therapeutic drugs. The tumor can also be attacked by decreasing its blood supply with genes that inhibit vascular growth. Another possible approach is to modify normal tissues with genes that make them more resistant to conventional drugs and/or radiation, thereby increasing the therapeutic index. Finally, it may be possible to attack the tumor indirectly by using genes that modify the behavior of the immune system, either by making the tumor more immunogenic, or by rendering host effector cells more efficient. Several gene therapy applications have already been reported for pediatric cancer patients in preliminary Phase 1 studies. Although no major clinical success has yet been achieved, improvements in gene delivery technologies and a better understanding of mechanisms of tumor progression and immune escape have opened new perspectives for the cure of pediatric cancer by combining gene therapy with standard therapeutic available treatments

    Dependence of DNA persistence length on ionic strength of solutions with monovalent and divalent salts: a joint theory-experiment study

    Full text link
    Using high-throughput Tethered Particle Motion single molecule experiments, the double-stranded DNA persistence length, LpL_p, is measured in solutions with Na+^+ and Mg2+^{2+} ions of various ionic strengths, II. Several theoretical equations for Lp(I)L_p(I) are fitted to the experimental data, but no decisive theory is found which fits all the LpL_p values for the two ion valencies. Properly extracted from the particle trajectory using simulations, LpL_p varies from 30~nm to 55~nm, and is compared to previous experimental results. For the Na+^+ only case, LpL_p is an increasing concave function of I1I^{-1}, well fitted by Manning's electrostatic stretching approach, but not by classical Odjik-Skolnick-Fixman theories with or without counter-ion condensation. With added Mg2+^{2+} ions, LpL_p shows a marked decrease at low II, interpreted as an ion-ion correlation effect, with an almost linear law in I1I^{-1}, fitted by a proposed variational approach

    Changement dans le risque fracturaire et le profil de fracture suivant la chirurgie bariatrique : étude de cohorte rétrospective utilisant les bases de données administratives de la RAMQ

    Get PDF
    La chirurgie bariatrique a des impacts positifs démontrés sur la santé cardiométabolique, sur la qualité de vie et sur la diminution de la mortalité, mais elle semble également affecter négativement l’intégrité osseuse. Bien que les études aient démontré un remodelage osseux augmenté, une perte de densité minérale osseuse et des altérations histomorphométriques suggestives d’ostéomalacie après la chirurgie bariatrique, peu d’études ont évalué son impact sur le risque fracturaire. Nos objectifs sont donc d’évaluer le risque fracturaire de patients ayant subi une chirurgie bariatrique comparativement aux contrôles obèses n’ayant pas subi de chirurgie et aux contrôles non-obèses, d’évaluer les sites fracturaires prédominants dans l’obésité et après la chirurgie bariatrique et de déterminer si le type de chirurgie bariatrique influence le risque fracturaire. Cette étude, réalisée grâce aux bases de données administratives de la Régie de l’assurance maladie du Québec (RAMQ), démontre que le risque fracturaire augmente avec le niveau d’obésité, que le profil de fracture se modifie après la chirurgie, passant d’un profil de fractures relié à l’obésité avant la chirurgie à un profil de type ostéoporotique en post-opératoire, et que la dérivation biliopancréatique est la seule chirurgie étant associée significativement à une augmentation du risque de fracture dans notre étude.Bariatric surgery has proven beneficial effects on cardiometabolic health, on quality of life and on mortality, but it also seems to negatively influence bone health. Although studies have shown an increase in bone remodeling, a decrease in bone mineral density and histomorphometric alterations suggesting osteomalacia after surgery, few studies have evaluated its impact on fracture risk. Our objectives are to evaluate fracture risk in obese individuals who submitted to bariatric surgery compared with obese and non-obese controls, to evaluate fracture sites in obesity and after bariatric surgery, and to evaluate if the type of surgery influences fracture risk. This study, using healthcare administrative databases, showed that fracture risk increases with the level of obesity, that pattern of fracture changes after surgery, from a pattern associated with obesity before surgery to a pattern typical of osteoporosis post-operatively, and that biliopancreatic diversion is the only type of surgery that was associated with a significant increase in fracture risk in our study

    A model for the molecular organisation of the IS911 transpososome

    Get PDF
    Tight regulation of transposition activity is essential to limit damage transposons may cause by generating potentially lethal DNA rearrangements. Assembly of a bona fide protein-DNA complex, the transpososome, within which transposition is catalysed, is a crucial checkpoint in this regulation. In the case of IS911, a member of the large IS3 bacterial insertion sequence family, the transpososome (synaptic complex A; SCA) is composed of the right and left inverted repeated DNA sequences (IRR and IRL) bridged by the transposase, OrfAB (the IS911-encoded enzyme that catalyses transposition). To characterise further this important protein-DNA complex in vitro, we used different tagged and/or truncated transposase forms and analysed their interaction with IS911 ends using gel electrophoresis. Our results allow us to propose a model in which SCA is assembled with a dimeric form of the transposase. Furthermore, we present atomic force microscopy results showing that the terminal inverted repeat sequences are probably assembled in a parallel configuration within the SCA. These results represent the first step in the structural description of the IS911 transpososome, and are discussed in comparison with the very few other transpososome examples described in the literature

    Probing DNA conformational changes with high temporal resolution by Tethered Particle Motion

    Full text link
    The Tethered Particle Motion (TPM) technique informs about conformational changes of DNA molecules, e.g. upon looping or interaction with proteins, by tracking the Brownian motion of a particle probe tethered to a surface by a single DNA molecule and detecting changes of its amplitude of movement. We discuss in this context the time resolution of TPM, which strongly depends on the particle-DNA complex relaxation time, i.e. the characteristic time it takes to explore its configuration space by diffusion. By comparing theory, simulations and experiments, we propose a calibration of TPM at the dynamical level: we analyze how the relaxation time grows with both DNA contour length (from 401 to 2080 base pairs) and particle radius (from 20 to 150~nm). Notably we demonstrate that, for a particle of radius 20~nm or less, the hydrodynamic friction induced by the particle and the surface does not significantly slow down the DNA. This enables us to determine the optimal time resolution of TPM in distinct experimental contexts which can be as short as 20~ms.Comment: Improved version, to appear in Physical Biology. 10 pages + 10 pages of supporting materia

    Introducing high-cost health care to patients: dentists' accounts of offering dental implant treatment

    Get PDF
    Objectives: The decision-making process within health care has been widely researched, with shared decision-making, where both patients and clinicians share technical and personal information, often being cited as the ideal model. To date, much of this research has focused on systems where patients receive their care and treatment free at the point of contact (either in government-funded schemes or in insurance-based schemes). Oral health care often involves patients making direct payments for their care and treatment, and less is known about how this payment affects the decision-making process. It is clear that patient characteristics influence decision-making, but previous evidence suggests that clinicians may assume characteristics rather than eliciting them directly. The aim was to explore the influences on how dentists' engaged in the decision-making process surrounding a high-cost item of health care, dental implant treatments (DITs). Methods: A qualitative study using semi-structured interviews was undertaken using a purposive sample of primary care dentists (n = 25). Thematic analysis was undertaken to reveal emerging key themes. Results: There were differences in how dentists discussed and offered implants. Dentists made decisions about whether to offer implants based on business factors, professional and legal obligations and whether they perceived the patient to be motivated to have treatment and their ability to pay. There was evidence that assessment of these characteristics was often based on assumptions derived from elements such as the appearance of the patient, the state of the patient's mouth and demographic details. The data suggest that there is a conflict between three elements of acting as a healthcare professional: minimizing provision of unneeded treatment, trying to fully involve patients in shared decisions and acting as a business person with the potential for financial gain. Conclusions: It might be expected that in the context of a high-cost healthcare intervention for which patients pay the bill themselves, that decision-making would be closer to an informed than a paternalistic model. Our research suggests that paternalistic decision-making is still practised and is influenced by assumptions about patient characteristics. Better tools and training may be required to support clinicians in this area of practice

    Genoscape: a Cytoscape plug-in to automate the retrieval and integration of gene expression data and molecular networks

    Get PDF
    Summary: Genoscape is an open-source Cytoscape plug-in that visually integrates gene expression data sets from GenoScript, a transcriptomic database, and KEGG pathways into Cytoscape networks. The generated visualisation highlights gene expression changes and their statistical significance. The plug-in also allows one to browse GenoScript or import transcriptomic data from other sources through tab-separated text files. Genoscape has been successfully used by researchers to investigate the results of gene expression profiling experiments

    TP53 transcription factor for the NEDD9/HEF1/Cas-L gene: potential targets in Non-Small Cell Lung Cancer treatment

    Get PDF
    International audienceLung cancer is a serious public health problem. Although there has been significant progress in chemotherapy, non-small cell lung cancer is still resistant to current treatments, primarily because of the slow rate of cell development. It is thus important to find new molecules directed against targets other than proliferation agents. Considering the high proportion of mutant proteins in tumor cells, and the high rate of mutation of the TP53 gene in all cancers, and in NSCLC in particular, this gene is a perfect target. Certain new molecules have been shown to restore the activity of mutated p53 protein, for example PRIMA-1, which reactivates the His273 mutant p53. In a previous study, we presented triazine A190, a molecule with a cytostatic activity that blocks cells in the G1 phase and induces apoptosis. Here, we show that A190 not only restores mutant p53 activity, but also induces an overexpression of the NEDD9 gene, leading to apoptotic death. These findings might offer hope for the development of new targeted therapies, specific to tumor cells, which spare healthy cell
    corecore